Universidad Peruana Cayetano Heredia

Treatment issues in multiple sclerosis in Latin America

Mostrar el registro sencillo del ítem

dc.contributor.author Vizcarra-Escobar, Darwin
dc.contributor.author Mendiola-Yamasato, A.
dc.contributor.author Anculle-Arauco, V.
dc.contributor.author Vizcarra-Pasapera, J.
dc.contributor.author Guillen-Mendoza, Daniel
dc.date.accessioned 2019-02-22T14:55:50Z
dc.date.available 2019-02-22T14:55:50Z
dc.date.issued 2015
dc.identifier.uri https://hdl.handle.net/20.500.12866/5795
dc.description.abstract Treatment issues of multiple sclerosis (MS) in Latin America (LA) have recently been addressed. Some particular features of the health systems, patients and medical providers are scarcely described. Moreover, LA patients are rarely included in clinical trials; therefore, data collected from key opinion leaders (KOL) from LA, although unofficial, remain as a needed source of information. In a stand-alone gathering, organized by a pharmaceutical company, in Brazil 2014, according to ‘Compliance Program Guidance for Pharmaceutical Manufacturers', we surveyed the opinion of KOL in MS from 6 LA countries. Neurologists were selected and invited to the gathering based on their academic, research and clinical experience with MS patients and involvement as participants and speakers on regional events. A voluntary anonymous electronic survey was proposed in an interactive lecture (table 1). Important definitions were given previously without further discussion on the topic to avoid biased answers. en_US
dc.language.iso eng
dc.publisher Karger
dc.relation.ispartofseries Neuroepidemiology
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Humans en_US
dc.subject Latin America en_US
dc.subject Brazil en_US
dc.subject Medication Adherence en_US
dc.subject Health Knowledge, Attitudes, Practice en_US
dc.subject Health Services Accessibility en_US
dc.subject human en_US
dc.subject health insurance en_US
dc.subject multiple sclerosis en_US
dc.subject drug efficacy en_US
dc.subject unclassified drug en_US
dc.subject questionnaire en_US
dc.subject South and Central America en_US
dc.subject Letter en_US
dc.subject health care delivery en_US
dc.subject drug tolerability en_US
dc.subject drug withdrawal en_US
dc.subject patient compliance en_US
dc.subject health survey en_US
dc.subject health care system en_US
dc.subject medication compliance en_US
dc.subject attitude to health en_US
dc.subject drug cost en_US
dc.subject physician attitude en_US
dc.subject drug industry en_US
dc.subject data base en_US
dc.subject neurologist en_US
dc.subject biosimilar agent en_US
dc.subject disease modifying drug en_US
dc.subject injection site pain en_US
dc.subject Multiple Sclerosis en_US
dc.subject skin manifestation en_US
dc.title Treatment issues in multiple sclerosis in Latin America en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1159/000373926
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.03.09
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.25
dc.relation.issn 1423-0208


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas